|
|
|
Advertisement |
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT
Register Now |
Advertisement |
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
Europe: Thursday, November 8, 2018 at 3pm GMT | 4pm CET
Register Now |
|
Advertisement |
Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
On Demand
Learn More |
|
|
The EU |
 |
The European Union Guessing Game |
The workings of the European Union are notoriously complicated, with the result that misunderstanding is commonplace, even among those who might like to know more about it.
... /Read more/ |
|
|
Advertisement |
Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now |
Advertisement |
IDENTIFYING NASH PATIENTS: Solutions and Strategies
Thursday, November 1, 2018 at 11am EDT
Register Now |
Advertisement |
A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
Register Now |
|
Advertisement |
Artificial Intelligence: A Transformative Journey for Pharmacovigilance
On Demand
Learn More |
Advertisement |
A Next Generation Sequencing Approach to Influenza Vaccine Development
On Demand
Learn More |
Advertisement |
Challenging the Status Quo: The Diffusion of Technology in Study Startup
On Demand
Learn More |
Advertisement |
Decoding the Distinction: DMCs, CECs, and Their Role in Medical Device Research
On Demand
Learn More |
|
|
The FDA |
 |
FDA Supports Streamlined Trials for New Antimicrobials |
The critical need for new medicines to combat infectious diseases is prompting FDA to join with other federal health agencies and the biomedical research community to advance the science, regulatory policies, and reimbursement strategies to promote innovation in this area.
... /Read more/ |
|
|
Advertisement |
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand
Learn More |
|
|
|